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PCR detection of viral pathogens is extremely useful, but suffers from the
challenge of detecting the many variant strains of a given virus that arise
over time. Here, we report the computational derivation and initial experimental testing of a combination of 10 PCR primers to be used in a single
high-sensitivity mixed PCR reaction for the detection of dengue virus. Primer sequences were computed such that their probability of mispriming
with human DNA is extremely low. A ‘cocktail’ of 10 primers was shown
experimentally to be able to detect cDNA clones representing the four serotypes and dengue virus RNA spiked into total human whole blood RNA.
Computationally, the primers are predicted to detect 95% of the 1688 dengue strains analyzed (with perfect primer match). Allowing up to one mismatch and one insertion per primer, the primer set detects 99% of strains.
Primer sets from three previous studies have been compared with the present set of primers and their relative sensitivity for dengue virus is discussed.
These results provide the formulation and demonstration of a mixed primer
PCR reagent that may enable the detection of nearly any dengue strain
irrespective of serotype, in a single PCR reaction, and illustrate an
approach to the broad problem of detecting highly mutable RNA viruses.

doi:10.1111/j.1742-4658.2011.08091.x

Introduction
Molecular methods are of increasing importance in
pathogen detection, and are gradually replacing serology and culturing in many applications. PCR is particularly widely used because of its great analytical
sensitivity, but requires primers with perfect or close
sequence match to the pathogen genome. Although it
is often not difﬁcult to design primers speciﬁc to an
individual strain of a pathogen, genetic drift and selection produces a variety of sequence variants that can

be difﬁcult to target effectively. This problem is especially pronounced with the mutation-prone RNA
viruses.
Dengue virus is a rapidly emerging mosquito-borne
positive-strand single-stranded RNA virus that infects
an estimated 50 million people annually [1]. Dengue
hemorrhagic fever is a severe form of dengue fever that
claims approximately 12 500 reported lives every year.
In the last four decades, dengue has spread from

Abbreviations
e-PCR, electronic-PCR; STS, sequence tagged site; NCBI, National Center for Biotechnology Information.
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approximately 10 countries to 100 (World Health
Organization: http://www.who.int/mediacentre/factsheets/
fs117/en/index.html, accessed September 2010), transmitted by the mosquito vectors Aedes aegypti and
Aedes albopictus. The virus occurs as four serotypes
(DENV-1 to DENV-4); all four serotypes can co-circulate in affected areas.
Despite extensive ongoing efforts, no vaccines for
dengue are yet available [2,3], and prevention can only
be achieved by arresting the multiplication of mosquito
vectors. For diagnosis, serological antigen-detection
[4,5] and antibody-detection tests [6,7] and nucleic
acid-based diagnostics [8–13] are in use, in addition to
virus culture from infected samples. Antibody-detection serological tests depend upon the appearance of
the host immune response 5–6 days after the onset of
fever. Similarly, virus isolation from infected sera is a
time-consuming process requiring 7 days of incubation
followed by screening for the presence of virus [14].
Nucleic acid-based assays offer rapid and speciﬁc
detection and serotyping of dengue virus, and are
gradually replacing serological and culture techniques.
These methods include nested RT-PCR [9], real-time
RT-PCR [10,12,13], loop-mediated isothermal ampliﬁcation [11], nucleic acid sequence-based ampliﬁcation
[15] and Taqman assays [8]. Although these methods
are rapid, they are subject to false-negative results. As
discussed below, the most widely cited early primer
sets [9,10,13] can detect a signiﬁcant fraction of dengue
strains only through priming involving multiple mismatches, increasing the probability of false-negative
results, induced by escape mutation or PCR failure.
Recently, we developed a set of novel algorithms
[16] for exhaustive identiﬁcation of all nucleotide
subsequences present in a pathogen genome that differ
by at least a chosen number of mismatches from
the sequences of the host and ⁄ or other background
genomes. Brieﬂy, the algorithm scans the genome
sequences of the target pathogen and the host,
creating lists of all subsequences of a speciﬁed length
n (‘n-mers’) occurring in each genome. The subse-

quences present within the pathogen genome are then
annotated according to the minimum number of base
changes required to convert each subsequence to the
nearest subsequence present in the host sequence. The
pathogen subsequences furthest from the host genome
are favored targets for probes or primers for the detection of that pathogen against that host background. It
was found that 99.99% of all possible 11-mers, 70% of
all 15-mers and 5% of all 18-mers are present in the
human genome [16]. A select few ‘human-blind’ dengue primers have previously been described [17].
In this work, in addition to the distance from the
nearest human sequence, primer sequences were also
selected based on their melting temperature, absence of
homopolynucleotide runs, predicted amplicon size and
serotype speciﬁcity. Candidate dengue-speciﬁc, humanblind primers were further categorized according to the
serotypes of the strains they were predicted to detect
into ﬁve groups of primer pairs (Table 1 and Tables
S1 and S2). Here, we report the preparation and testing of a mixture of 10, 18- to 22-nucleotide PCR primers, each of which is at least two mismatches away
from the nearest human sequence. Following the
nomenclature of Koekemoer et al. (2002) [18], we refer
to this multiple primer pair ⁄ one template strategy as
‘cocktail PCR’ to differentiate it from multiplex PCR,
in which more than one target is ampliﬁed. The cocktail is composed of one primer pair from each of the
ﬁve primer pair groups, which together are predicted
to detect nearly any strain of the four dengue virus serotypes. This cocktail is computationally predicted to
detect 1610 of 1688 DENV strains listed in the Broad
Institute Dengue Virus Database (http://www.broad.
mit.edu/annotation/viral/Dengue/Home.html, accessed
July 2009) as of July 2009, with perfect primer match,
and 512 of 516 additional geographically dispersed
strains obtained from National Center for Biotechnology Information (NCBI) in January 2011. Computational predictions of sensitivity* of the primer cocktail
for the 2204 dengue strains considered and corresponding experiments with both dengue cDNA clones and

Table 1. Strain coverage of the five primer groups in set 1. Each entry is the number of the 163 design-basis strains in the row associated
with that serotype covered by the primers of the group associated with that column; the primers are categorized according to the strains
that they detect. The number of primer pairs in each group is indicated in the column header. See details in Table S1.
Number (percentage) of strains of row serotype covered by column primer group
Dengue serotype
(no. of strains in
design basis set)

Group 1
(1 primer pair)

Group 2
(1 primer pair)

Group 3
(48 primer pairs)

Group 4
(311 primer pairs)

Group 5
(35 primer pairs)

DENV-1
DENV-2
DENV-3
DENV-4

7 (18.4%)
60 (93.7%)
0
0

12 (31.5%)
40 (62.5%)
0
0

37 (97.3%)
0
0
0

0
0
45 (100%)
0

0
0
0
16 (100%)

(38
(64
(45
(16

strains)
strains)
strains)
strains)
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viral RNA of all four serotypes are reported here. The
results of this study demonstrate the use of these
human-blind primers for speciﬁc dengue virus detection and their implementation in a primer cocktail
strategy enabling high sensitivity for dengue strains
and facilitating a rapid detection method. *In this
paper, ‘sensitivity’ refers to the diagnostic sensitivity,
which is different from analytical sensitivity. Diagnostic sensitivity is the indicator of true-positive calls for a
pathogenesis, whereas analytical sensitivity is the detection limit of a detection method ⁄ assay [19].
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Human-blind dengue primers
Primers were tested for speciﬁc ampliﬁcation of DENV
cDNA in the presence of excess human DNA. The
mass ratio of DENV to human DNA was 1 : 1000 and
the molar ratio was 1 : 0.005 (a molar ratio of approximately 1 : 5 was also tested and showed identical
results). Primers from set 1 were tested experimentally
for optimum annealing temperature determination,
human-blindness conﬁrmation, single amplicon formation and cross-reactivity with other serotypes. Primers
were also tested computationally to determine their
strain sensitivity. The set 1, group 2 primer pair
1G2P1 was predicted to detect only 95% of DENV-2
strains, and it was replaced with a primer pair from set
2, group 2 (2G2P5) to increase predicted sensitivity for
DENV-2 strains (to 100% of the strains tested).
Experimental testing found that the primers ampliﬁed dengue and not human DNA. As an example,
ampliﬁcation curves of DENV-4 (GU289913) with all
ﬁve primer groups are shown in Fig. 1. As predicted
(Table 1), no ampliﬁcation of DENV-4 by primers
from groups 2, 3 or 4 was observed, although group 1
primers showed an increase in ﬂuorescence in the last
(35th) PCR cycle. No ampliﬁcation of human DNA
was observed with any of the primers. Figure 2 shows
agarose gel electrophoresis of the ampliﬁcation products; identical amplicons were observed in the presence
and absence of excess human DNA. The melting Tm
of amplicons formed in the presence and absence of
human DNA was 81.1 ± 0.28 C (n = 4) and 81.1 ±
0.29 C (n = 10), respectively. Furthermore, PCR was
highly reproducible for each primer pair; coefﬁcients
of variation in Ct values for group 1 primer pair
1G1P1 (which detects both DENV-1 and DENV-2)
were 2.0 and 0.9% for DENV-1 and DENV-2, respectively, and 1, 1.8, 4.4 and 3.4% for groups 2 (2G2P5),
3 (1G3P6), 4 (1G4P217) and 5 (1G5P30), respectively,
with the strains that they detect.
1678
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Fig. 1. Real-time PCR amplification of DENV-4 (GU289913) with
and without human DNA. Group 5 primers (1G5P30, as used in the
‘cocktail’ mixture) amplified DENV-4 (GU289913) in the presence of
1000-fold excess human DNA (squares) and the absence of human
DNA (diamonds) under optimal PCR conditions. Group 1 (triangles),
group 2 (crosses), group 3 (circles) and group 4 (asterisks) primers
showed inefficient or no amplification, as predicted. Group 1
primers showed some amplification in the last cycle of the PCR.
The amplification threshold was set at a baseline-subtracted
fluorescence value of 990 (horizontal line).
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Fig. 2. Agarose gel electrophoresis of PCR products obtained with
DENV-4 (GU289913). Lane 1, Hi-Lo DNA marker; lane 2, PCR with
group 1 primers; lane 3, group 2 primers; lane 4, group 3 primers;
lane 5, group 4 primers; lane 6, group 5 primers; lane 7, group 5
primers in the presence of 1000-fold excess human DNA; lane 8,
group 5 primers with human DNA alone; lane 9, no-template control for group 5 primers. Each primer pair tested is a component of
the highly sensitive primer cocktail discussed in this work (Table 2).
PCR was performed at a consensus annealing temperature of
60 C for 60 s, and extension at 72 C for 90 s for 35 cycles.

Primers detected the serotypes they were predicted to
detect; there were no false negatives for any of the
primer groups. Speciﬁcity for dengue is expected to be
very good; the primers were predicted to be speciﬁc to
dengue virus when computationally tested against 291
strains of other nondengue ﬂaviviruses, including strains
of Japanese encephalitis virus, St. Louis encephalitis
virus, West Nile virus and yellow fever virus (and also
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Table 2. Primer pairs that make up the highly sensitive primer cocktail discussed in this work. Note that 1G1P1 is listed twice because it
covers both DENV-1 and DENV-2, and that only the group 2 primer pair was taken from set 2. An average primer sequence location across
multiple strains of each serotype is shown, together with the predicted average amplicon size. The primer orientation is 5¢ to 3¢. Detailed
information on the recognition of each of the 1688 Broad Institute database strains by each primer is given in Table S7.

Primer group

1G1P1

Group 1

1G1P1

Group 1

2G2P5

Group 2

1G3P6

Group 3

1G4P217

Group 4

1G5P30

Group 5

CAAACCATGGAAGCTGTACG
TTCTGTGCCTGGAATGATGCT
CAAACCATGGAAGCTGTACG
TTCTGTGCCTGGAATGATGCT
GAGTGGAGTGGAAGGAGAAGGG
CCTCTTGGTGTTGGTCTTTGC
CAGACTAGTGGTTAGAGGAGA
GGAATGATGCTGTAGAGACA
ATATGCTGAAACGCGTGAG
CATCATGAGACAGAGCGAT
TTCCAACAAGCAGAACAACAT
GCTACAGGCAGCACGGTTT

against the genome of the carrier organism Aedes aegypti, which might be useful for insect screening). Speciﬁcity among DENV serotypes was very good, but not
perfect; the DENV-3 cDNA clone was detected by primer groups beyond the expected (Table 1) group 4. As
discussed below, these ampliﬁcation products were predicted by electronic-PCR (e-PCR) when one mismatch
and one gap were allowed. A very faint unpredicted
ampliﬁcation of DENV-4 by 1G1P1 primers (Fig. 2,
lane 2 near 250 bp) was also observed in the last ampliﬁcation cycle (Fig. 1). Ampliﬁcation curves and the
respective thermal dissociation curves of DENV-1,
DENV-2 and DENV-3 cDNA with all ﬁve primer
groups in the presence and absence of 1000-fold excess
human DNA are shown in Figs S1–S6.
Primer testing with DENV and human RNA
Primers were further tested with total RNA extracted
from DENV-1 (Piura, Peru)-, DENV-2 (New Guinea C)-,
DENV-3 (Asuncion, Paraguay)- or DENV-4 (Dominica,
West Indies)-infected C6 ⁄ 36 mosquito cells. Figure 3
shows a comparison of real-time ampliﬁcation curves of
total RNA extracted from DENV-2 (New Guinea C)infected C6 ⁄ 36 cells (with and without RT), and uninfected C6 ⁄ 36 cells. As expected, only DENV-2-infected
C6 ⁄ 36 cells showed ampliﬁcation, and only in the presence of RT. No ampliﬁcation was observed with total
RNA of normal C6 ⁄ 36 A. albopictus cells or in the
absence of template. DENV-2 was ampliﬁed by primers
1G1P1 and 2G2P5 and, as expected, not ampliﬁed by
primers from groups 3, 4 and 5. Identical products
were formed by PCR of DENV-2 cDNA and RT-PCR

Dengue
serotype

Average amplicon
location (nucleotides)

Average amplicon
size (bp)

DENV-1

10451
10671
10438
10660
9057
9305
10482
10661
104
382
9903
10318

219

DENV-2
DENV-2
DENV-1
DENV-3
DENV-4

221
248
179
279
415

of DENV-2 RNA with the 2G2P5 primer pair, as
seen in the amplicon melting curves [Fig. 4; Tm =
79.9 ± 0.40 C (n = 4) and 79.7 ± 0.25 C (n = 4),
respectively] and by agarose gel electrophoresis (Fig. 5).
Ampliﬁcation and melting temperature curves of amplicons obtained by real-time RT-PCR with DENV-1,
DENV-2, DENV-3 and DENV-4 RNA in the absence
and presence of human whole blood total RNA are

5000

Fluorescence (dR)

Primer pair

Primer sequence
5¢-Forward-3¢
5¢-Reverse-3¢

3250

1500

–250
0

5

10

15
20
Cycles

25

30

35

Fig. 3. Real-time RT-PCR of DENV-2 (New Guinea C)-infected
C6 ⁄ 36 cell total RNA using cocktail primers (Table 2). Cocktail primers of group 1 (1G1P1), group 2 (2G2P5), group 3 (1G3P6), group 4
(1G4P217) and group 5 (1G5P30) were used. DENV-2 New Guinea
C-infected C6 ⁄ 36 cell total RNA was amplified by group 1 (circles)
and group 2 (squares) primers as predicted. No amplification was
seen with any of the following: no-RT controls; uninfected C6 ⁄ 36
cell control; no-template control; and primers from any other of the
three groups (not shown). The amplification threshold was set at a
baseline-subtracted fluorescence value of 674 (horizontal line).
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human blood total RNA; the ampliﬁcation was too
weak for the product to be observable in Fig. 5.

6500

Fluorescence (-R' (T ))

5500

Cocktail PCR
4500
3500
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–500
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Fig. 4. Thermal dissociation curves of products of real-time RTPCR amplification of DENV-2 New Guinea C (M29095) RNA
(squares) and cDNA (circles). Total RNA of DENV-2 (New Guinea
C)-infected C6 ⁄ 36 cells resulted in an identical PCR product with
Tm = 79.7 C, as compared with a DENV-2 cDNA clone with
Tm = 79.9 C. The results for group 2 primer pair 2G2P5 are
shown.
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Fig. 5. Products of PCR amplification of DENV-2 New Guinea C
(M29095) RNA and cDNA. Amplification of DENV-2 cDNA and total
RNA from DENV-2 (New Guinea C)-infected C6 ⁄ 36 cells with the
2G2P5 primer pair in the absence and presence of human DNA or
RNA. Lane 1, Hi-Lo DNA size marker; lane 2, PCR products
obtained with 2G2P5 primers and DENV-2 cDNA plasmid clone;
lane 3, DENV-2 (New Guinea C) cDNA in the presence of 1000-fold
excess human genomic DNA; lane 4, DENV-2 (New Guinea C)infected C6 ⁄ 36 cells total RNA; lane 5, DENV-2 RNA in the presence of 100-fold excess human whole blood total RNA; lane 6,
human RNA alone; lane 7, uninfected C6 ⁄ 36 cells total RNA; lane
8, no-RT control of DENV-2-infected C6 ⁄ 36 cells total RNA; lane 9,
no-template control. RT-PCR was carried out with 100 nM primer
concentration at 60 C annealing temperature, for 35 cycles.

shown in Figs S7–S14. Identical amplicons were
obtained in the absence and presence of a 100-fold mass
excess of human RNA. Primer pair 2G2P5 gave weak
ampliﬁcation very late in the PCR (at cycle 33–35) with
1680

A major goal of this work was to advance the development of a single-PCR diagnostic tool with broad sensitivity across dengue strains and serotypes. In support
of this goal, after validating the sensitivity and speciﬁcity of the individual primer pairs, we blended ﬁve primer pairs together to produce a ‘cocktail’ expected to
give one or more products with any of the dengue
virus strains used in the primer design, representing all
four serotypes. In contrast to multiplex PCR, in this
assay, multiple products are not essential (or problematic), but could potentially contribute additional information upon electrophoretic analysis and might
increase the sensitivity to strains not considered in the
design.
Experimentally, a single cocktail of primers was
found to be able to detect test strains representing all
of the DENV serotypes. All serotypes, with the exception of DENV-4, produced expected multiple amplicons with the 10-primer cocktail, as seen by
electrophoretic analysis (Fig. 6A). The amplicon band
pattern observed was not affected by the presence of
excess human DNA. No template and human DNA
controls did not show any ampliﬁcation. Amplicons
obtained with real-time RT cocktail PCR of all four
serotypes of DENV RNA in the absence and presence
of human RNA (Fig. 6B) were not affected by the
presence of excess human RNA. No template (not
shown) and human RNA-only controls showed no
ampliﬁcation.
Multiple amplicons were obtained with a single template, as expected in cocktail PCR. Products obtained
by the ampliﬁcation of a sequence lying between the
sites recognized by a forward primer belonging to one
group and a reverse primer belonging to another group
were termed ‘hybrid’ products. The multiple hybrid
products generated from most templates (see Fig. 6A)
were observed to be predictable (see Table S3) and
highly reproducible, and could potentially be used to
identify serotypes or even genotypes. The existence of
multiple amplicons may enhance resistance to false
negatives produced by escape mutants of these mutable
RNA viruses.
e-PCR-based dengue virus detection sensitivity
Ampliﬁcation by the primer cocktail was predicted by
e-PCR for all 1688 strains in the Broad Institute
Dengue Virus Database as of July 2009, and by
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show a signiﬁcant match to any of these 11 strains (the
group 1 forward primer had four mismatches with all
strains and the reverse primer had seven to 13 mismatches). The group 3 primer pair 1G3P6F forward
primer matched eight strains perfectly, two strains
(FJ850075 and FJ850073) with one mismatch and
missed one strain (FJ639812) with four mismatches.
The reverse primer, 1G3P6R showed three to 13 mismatches with these 11 strains.

50

Geographical variation in dengue virus
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Fig. 6. Ten-primer cocktail PCR with all four serotypes: band patterning. Amplification with 10 primers (25 combinations) gives multiple specific products, as predicted (see Table S3). PCR products
of amplification of dengue cDNA clones (A) and RNA (B) (DENV-1,
DENV-2, DENV-3 and DENV-4) using primer cocktail in the absence
()H) and presence (+H) of human DNA where the mass ratio of
human DNA to dengue cDNA was 1000 and human RNA to dengue RNA was 100–1000, as visualized by agarose gel electrophoresis. M, Hi-Lo DNA size marker; NTC, no-template control; H,
human RNA alone.

MegaBLAST for 516 additional geographically dispersed strains obtained from NCBI in January 2011.
Of the 1688 available dengue virus genome sequences,
the primer cocktail was predicted by e-PCR to detect
1610 (95%), with perfect primer matches (Table 4;
Table S4), missing 3.4% of 748 DENV-1, 0.5% of 568
DENV-2, 14.5% of 316 DENV-3 and 5.3% of 56
DENV-4 strains tested. With reduced stringency,
allowing one mismatch and one insertion per primer,
1675 of 1688 strains were predicted to be detected
(99%) (Table 4; Table S5). Of the 13 ‘missed’ strains,
the two belonging to the DENV-2 serotype (accession
numbers FJ913016.1 and GQ199605.1) were partial
genome sequences missing both primer target regions.
The remaining 11 strains (all DENV-1) were analyzed
for sequence match with both primer groups 1 and 3
using blastn, as primers from both groups can detect
DENV-1. The group 1 primer pair 1G1P1 did not

Of the 516 strains with complete genome sequences
analyzed, 512 were predicted to be detected by the primer cocktail (Table S6). The four missed strains
belonged to DENV-1 (GenBank accession numbers
FJ469907, FJ469908, FJ469909 and HM181969). As
before, group 1 primers did not show any match to
these missed strains and group 3 forward primers
matched perfectly. The group 3 reverse primer showed
no match. These sequences were found to be 10 454–
10 642 bp long. As the average primer location of
group 3 primers is 10 661 ± 4.8 bp, based on 729
DENV-1 genome sequences (Table S7), it is likely that
these strains were predicted not to be detected because
of a missing sequence at the 3¢ end.
Amplification efficiencies and analytical
sensitivity of the primers
Ampliﬁcation efﬁciencies calculated for primer pairoptimized PCR conditions and consensus cocktail
PCR conditions are shown in Table 3. The consensus
reaction conditions represent a workable compromise
for all the primers in a single-tube reaction. Cocktail
ampliﬁcation efﬁciencies, therefore, are not identical to
those under conditions optimized for a single primer
pair. Under optimal PCR conditions, at the ampliﬁcation efﬁciencies values listed in Table 3, the detection
limit of the dengue cDNA plasmid clones was 2.5 moleculesÆlL)1 for all serotypes and primer groups, with
the exception of group 5 primers with DENV-4 where
the detection limit was 25 moleculesÆlL)1. Under
compromise consensus cocktail PCR conditions, at the
ampliﬁcation efﬁciency values listed in Table 3, the
detection limit of the dengue cDNA plasmid clones
was 2400 moleculesÆlL)1 for DENV-1, 24 moleculesÆlL)1 for DENV-2, 240 moleculesÆlL)1 for
DENV-3 and 24 000 moleculesÆlL)1 for DENV-4. The
detection limit for DENV-4 improved 100-fold to
240 moleculesÆlL)1 when the concentration of group 5
primer pair 1G5P30 was doubled to 100 nm in the
primer cocktail.
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Table 3. Amplification efficiency of primer pairs. Efficiency is reported under conditions optimized for each primer pair and also for the consensus cocktail PCR conditions: primer concentration 50 nM each; annealing temperature 60 C; extension time 60 s (n ‡ 3; R 2 ‡ 0.995;
average R 2 = 0.997).

Primer pair
1G1P1
1G1P1
2G2P5
1G3P6
1G4P217
1G5P30

Primer sequence
5¢-Forward-3¢
5¢-Reverse-3¢
CAAACCATGGAAGCTGTACG
TTCTGTGCCTGGAATGATGCT
CAAACCATGGAAGCTGTACG
TTCTGTGCCTGGAATGATGCT
GAGTGGAGTGGAAGGAGAAGGG
CCTCTTGGTGTTGGTCTTTGC
CAGACTAGTGGTTAGAGGAGA
GGAATGATGCTGTAGAGACA
ATATGCTGAAACGCGTGAG
CATCATGAGACAGAGCGAT
TTCCAACAAGCAGAACAACAT
GCTACAGGCAGCACGGTTT

Average efficiency ± SD
Template

Optimal PCR conditions

Cocktail PCR conditions

DENV-1

90.0 ± 1.50

89.5 ± 2.52

DENV-2

98.9 ± 6.23

98.9 ± 6.23

DENV-2

98.4 ± 0.84

98.4 ± 0.84

DENV-1

92.1 ± 0.57

73.6 ± 2.31

DENV-3

90.3 ± 1.09

83.9 ± 5.16

DENV-4

81.8 ± 5.03

79.0 ± 1.83

Table 4. Comparison of dengue strain coverage with primers of previously published studies using e-PCR. e-PCR predictions were performed with the requirement of perfect match (first number in each cell) and also allowing up to one mismatch and one gap per primer (second number in each cell).
Dengue serotypes

Number of strains tested

Present study

Lai et al. [13]

DENV-1
DENV-2
DENV-3
DENV-4
TOTAL

748
568
316
56
1688

722 ⁄ 737
565 ⁄ 566
270 ⁄ 316
53 ⁄ 56
1610 ⁄ 1675

0 ⁄ 619
152 ⁄ 456
0 ⁄ 307
0 ⁄ 55
152 ⁄ 1437

Discussion
We describe the formulation of a universal primer
reagent predicted to detect 1610 of the 1688 dengue
strains, irrespective of serotype, curated in the Broad
Institute Dengue Virus Database, as of July 2009. We
demonstrated the broad strain sensitivity of this
reagent using DENV cDNA clones and RNA of the
four serotypes in the presence of a vast excess of
human DNA and RNA. The reagent has high analytical sensitivity and speciﬁcity to the presence of dengue
virus cDNA clones, even in a vast excess of contaminating human DNA. Serotyping potentially could be
achieved by electrophoretic analysis of hybrid products
(Fig. 6A, B; all predicted products of ampliﬁcation of
each of the 1688 tested strains with the 10 cocktail
primers and with the primers of Lanciotti et al. [9], Lo
et al. [10] and Lai et al. [13] are tabulated in Tables S4
and S5). Serotyping could also be achieved by using
these primer pairs in separate reactions. However, our
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Lanciotti et al. [9]
0⁄0
0⁄0
0 ⁄ 251
0⁄1
0 ⁄ 252

Lo et al. [10]
623 ⁄ 737
219 ⁄ 532
309 ⁄ 316
0 ⁄ 54
1151 ⁄ 1639

immediate goal was high sensitivity for a broad range
of dengue virus strains.
The predicted strain sensitivity of PCR using the
cocktail described in this work was compared using
e-PCR with the predicted sensitivities of some earlier,
widely cited primers [9,10,13]. To maintain uniformity,
the multiple primers of previous studies were also treated as a cocktail and, hence, detection by any possible
hybrid pairs was also considered (Table 4; details in
Tables S4 and S5). It should be noted that previously
described primers, particularly those of the pioneering
and widely cited study of Lanciotti et al. [9] have lost
some predicted sensitivity with the sequencing of a
very large number of additional dengue strains since
that time.
On lowering the stringency of search by allowing
one mismatch and one gap per primer, the sensitivity
of all primer sets increased such that of the 1688 dengue strains, the present primer cocktail was predicted
to detect 1675 strains, whereas the previous primer sets
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were predicted to detect 1437 [13], 252 [9] and 1639
[10] strains, as shown in Table 4. It should be noted
that multiple mismatch priming can enhance empirically observed sensitivity beyond that predicted computationally. Although this primer cocktail is predicted
to have excellent sensitivity, it fails to detect  5% of
the strains and further analysis is required to determine the causes. Sequence variation due to wide geographical distribution did not have an effect on the
performance of the cocktail, supporting the potential
use of these primers globally. The primer cocktail
reagent will enable sensitive and speciﬁc dengue virus
detection when serotyping is not immediately required.
Such a method will be helpful to a dengue-speciﬁc
drug therapy, when it is available [20]. Rapid detection
is also of importance to prevent the development of
dengue hemorrhagic fever. Additionally, the broad sensitivity of the primer cocktail will also aid in better epidemiological characterization of the virus.
These results provide a demonstration of the high
projected sensitivity of human-blind dengue primers
and the operation of the primer cocktail strategy for
dengue virus detection. These primers are available for
testing with dengue strains at a larger scale to support
the development of a rapid clinical PCR detection
method. Perhaps most importantly, the methodology
described in this work could be generally applied to
the problem of developing broadly useful diagnostics
for mutable pathogens, especially RNA viruses.

Materials and methods
Primer selection
Potential primers (18–22 nucleotides in length) derived from
an exhaustive search of 163 dengue virus genomes were
screened against the complete human genome (build 34).
Primers that differed from the nearest sequence in the
human genome by at least two mismatches were subjected
to further screening using PCR primer design criteria [16].
The expected melting temperature Tm was calculated using
the nearest-neighbor model of SantaLucia et al. [21] and
was required to be between 50 and 65 C; homopolynucleotide stretches of more than three bases were not allowed.
Primers that passed this screening were paired based on Tm
difference; expected amplicon size with dengue templates
and potential for primer–dimer formation. The melting
temperatures of the forward and reverse primer of each pair
were required to differ by < 5 C and the predicted amplicon length was required to be 150–500 bp. Primer pairs
were rejected on the basis of possible primer–dimer formation if a candidate primer pair had four or more consecutive complementary nucleotides.

PCR detection of nearly any dengue virus strain

Primer strain coverage and serotype specificity
A set of human-blind candidate primer pairs was identiﬁed
using all 163 dengue virus genome sequences recorded in
GenBank as of March 2007, and termed set 1 (Table 1 and
Table S1). Five groups of primer pairs emerged when these
were categorized based on the strain coverage of each primer pair. Notably, in set 1, grouping the primers by dengue
strain coverage resulted in ﬁve groups, two of which
(groups 1 and 2) consisted of only one primer pair each.
Against the possibility that one or both of these single
primer pairs would fail to meet selection criteria and ⁄ or
experimental validation, another choice of primers for
group 1 and group 2 was selected and was referred to as
set 2 (Table S2). Set 1 consisted of 396 primer pairs categorized into ﬁve groups according to their strain coverage
(Table 1). For instance, any one of the 48 primer pairs in
group 3 is predicted to detect 37 of the 38 DENV-1 strains
in the 163-strain design basis set, and no strain of any other
serotype. By selecting one primer pair from each group,
nearly any of the 163 design-basis dengue strains may in
principle be detected. Thus, a cocktail combining one primer pair from each of the ﬁve groups from set 1 or set 2 is
predicted to be able to detect almost any of the 163 strains,
covering all four serotypes.

Flavivirus specificity of dengue primers
The speciﬁcity of the dengue primers was tested against 291
nondengue ﬂaviviruses, including 67 strains of Japanese
encephalitis virus, 28 strains of St Louis encephalitis virus,
172 strains of West Nile virus and 24 strains of yellow fever
virus using BLASTn [22]. The genome sequences of the
ﬂaviviruses were retrieved from Flavitrack (http://carnot.
utmb.edu/ﬂavitrack/; [23,24]). The primers were also tested
against the genome of the carrier mosquito Aedes aegypti.

Primers tested in the present study
For the present study, one primer pair was selected from
each of the ﬁve groups, originally from set 1. This was done
by ﬁrst testing the single primer pair in group 1 and group
2 and 10 randomly selected primer pairs each from groups
3, 4 and 5 from set 1. Subsequent selection was based on
empirical performance under standard PCR test conditions
of 100 nm primer concentration and 60 C annealing temperature. These conditions were considered desirable for
ampliﬁcation under cocktail PCR conditions where multiple
primers are required to be functional and the annealing
temperature needs to be stringent. The chosen primers
(Table 2) were empirically tested for sensitivity, speciﬁcity
and ampliﬁcation efﬁciency with one strain of each serotype
and then subjected to computational testing against all
1688 dengue strains in the Broad Institute Dengue Virus
Database, as of July 2009. The sensitivity of the set 1,
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group 2 primers for multiple strains was found to be low,
and they were replaced with set 2, group 2 primers. The
source of the primer pair is represented in the nomenclature
used below. For example, the primer name 2G2P5 identiﬁes
that the primer pair is from set 2, group 2, and is primer
pair number 5 in serial order within that group (see listings
in Tables S1 and S2).

Dengue virus templates for experimental testing
Primers were initially tested with dengue virus cDNAs
cloned in the yeast–Escherichia coli shuttle vector pRS424.
DENV-1 West Paciﬁc (U88535), DENV-2 New Guinea C
(M29095), DENV-3 (FJ639719) and DENV-4 (GU289913)
clones were kindly provided by B. Falgout, B. Zhao and
R. Levis of the US Food and Drug Administration.
Following tests with cDNA clones, primers were also
tested with DENV-1 (Piura, Peru), DENV-2 New Guinea
C (M29095), DENV-3 (Asuncion, Paraguay) and DENV-4
(Dominica, West Indies) RNA. The DENV-infected C6 ⁄ 36
mosquito (A. albopictus) cells and uninfected C6 ⁄ 36 mosquito cell samples were generously provided by R. B.
Tesh, Director of the World Reference Center for Emerging Viruses and Arboviruses at the University of Texas
Medical Branch at Galveston, TX, USA. Samples were
supplied as TRIzol (Invitrogen, Carlsbad, CA, USA)
extracts and further puriﬁed by phenol ⁄ chloroform extraction to obtain total RNA from both infected and control
normal cells. Total RNA was used as the template for
real-time RT-PCR. Dengue virus cDNA and RNA were
tested in the absence or presence of a large excess of
human genomic DNA (1000-fold by mass) or human
whole blood RNA (100–1000-fold by mass) extracted
using QIAamp Blood RNA Mini kit (Qiagen, Valencia,
CA, USA) to demonstrate the human RNA-blind property
of the primers. Anonymized normal donor blood was purchased from Gulf Coast Regional Blood Center (Houston,
TX, USA).

PCR amplification of dengue cDNA clones and
cocktail PCR
PCR reactions were conducted in 25 lL containing up to
100 pg ( 6 million plasmid copies, or in dilution series for
efﬁciency determinations as described below) of cDNA template (added in 1.0 lL), 12.5 lL 2 · Brilliant II SYBR
Green Q-PCR master mix, 100 nm of each forward and
reverse primer and nuclease-free water. Identical thermocycling conditions were used for all ﬁve groups of primers –
initial activation of polymerase (95 C, 10 min), followed
by 35 cycles of DNA denaturation (95 C, 1 min), primer
annealing (60 C, 1 min) and primer extension (72 C,
40 s). Controls omitting DNA template were included in
each experiment. An Mx3005P QPCR system (Agilent
Technologies, Santa Clara, CA, USA) was used for thermo-
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cycling and its software mxpro version 3.04b was used for
data collection and analyses. The coefﬁcient of variation in
the Ct values was obtained by dividing the standard deviation by the arithmetic mean of the ampliﬁcation Ct values.
All experiments were carried out in triplicate on different
days. Amplicons were visualized after 1.5% agarose gel
electrophoresis using SYBR Gold nucleic acid gel stain
(Molecular Probes, Eugene, OR, USA).
To produce the broad-sensitivity primer cocktail, one primer pair each from the ﬁve primer groups was mixed
together such that the ﬁnal concentration of each primer in
the PCR reaction was 50 nm. Other PCR conditions were
identical to those described above except that the extension
time was increased to 60 s.

Real-time RT-PCR amplification of dengue RNA
and cocktail RT-PCR
Real-time RT-PCR was employed to detect DENV-1 (Piura,
Peru), DENV-2 (New Guinea C), DENV-3 (Asuncion,
Paraguay) or DENV-4 (Dominica, West Indies) RNA present in total RNA extracted from infected C6 ⁄ 36 mosquito
cells. cDNA was synthesized directly using the primers
described in Table 2. In a 25 lL PCR reaction, either
100 pg of DENV-1-, 1 ng of DENV-2-, 100 pg of DENV3- or 1 ng of DENV-4-infected C6 ⁄ 36 cells total RNA was
used for cocktail PCR. The primer cocktail was composed
of 100 nm each of 1G1P1, 1G3P6, 1G4P217, 1G5P30 and
50 nm of 2G2P5 primer pairs (Table 2). PCR was carried
out in the absence or presence of human RNA. All tests
with spiked human RNA were performed unblinded.
Brilliant II SYBR Green QRT-PCR master mix kit,
1-Step (Agilent Technologies) and Mx3005P QPCR system were used for thermocycling. mx3005p software version
3.04b was used for data collection and analyses, with the
‘ampliﬁcation-based threshold’ algorithm and an adaptivebaseline correction used to determine the threshold cycle Ct.
The ampliﬁcation was considered positive when the Ct value
was < 30 cycles. The mean Tm of the amplicons with standard deviation or Tm curves were reported when comparing
the ampliﬁcation of cDNA and RNA, or ampliﬁcation in
the absence and presence of human nucleic acids.

Primer amplification efficiencies
Standard curves were constructed by ampliﬁcation of a
10-fold dilution series of each of the four dengue cDNAs
with their respective primer pairs. Template amounts of
1 fg ( 60 cDNA copies) to 10 ng (600 million cDNA
copies) were used, together with no-template controls. The
primer concentration and annealing temperature were optimized for each primer pair (Table S8), and each was also
tested under the consensus ‘cocktail’ conditions. The extension time was adjusted in the range of 40–90 s, depending
on the length of the expected amplicon (180–415 nucleo-
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tides). An extension time of 60 s was used for consensus
cocktail PCR; see above.

Amplification efficiency of primers under
consensus cocktail PCR conditions
The ampliﬁcation efﬁciency of each primer pair also was
determined under the consensus cocktail PCR conditions
(50 nm each primer, annealing temperature 60 C, extension
time 60 s). A seven point standard curve was constructed by
ampliﬁcation of a dilution series (template amount 1 fg to
1 ng) of each of the four dengue cDNAs with their respective
primer pairs (Table 2). Nontemplate controls were included.
Agilent’s mxpro software v3.04b uses a least mean squares
curve ﬁtting algorithm to generate standard curves by plotting the initial template amount on the x-axis and the threshold cycle (Ct) on the y-axis. The PCR efﬁciency is given by
10()1 ⁄ slope) ) 1, where the slope is )3.322 when the efﬁciency
is 100% [25]. The R2 value is also reported.

Reverse e-PCR testing of the primer cocktail with
1688 strains of dengue virus
To predict the sensitivity of the primer cocktail to diverse
strains of the virus, reverse e-PCR [26] was employed to
search viral sequences with the candidate primer pairs as
query sequences for sequence tagged sites (STSs). In this calculation, an STS is deﬁned by a primer pair ﬂanking the site
in appropriate orientation and the length of the STS is the
expected PCR product size. The ﬁve forward and ﬁve reverse
primers of the cocktail were considered in all 25 possible forward-reverse pairings (Table S3). Dengue virus genome
sequences were obtained and downloaded from the Broad
Institute Dengue Virus Database so that the reverse e-PCR
could be run locally. Search parameters included either a perfect match between the primer and the dengue sequence or a
maximum of one mismatch and one gap allowed per primer;
the expected PCR product size was required to be 50–
1000 bp. Additionally, the sensitivity of previously published
primer sets (as cocktails) was predicted for comparison.

Effect of geographical variation in dengue virus
on the performance of the primer cocktail
Each of the four serotypes of dengue virus can be classiﬁed into several genotypes, deﬁned as a group of viruses
having no more than 6% sequence divergence [27]. To
predict the performance of the primer cocktail when tested
with geographically widespread dengue strains, 516 strains
of DENV-1, DENV-2 and DENV-3 were analyzed.
DENV-4 was not considered in detail in this analysis
because only 87 DENV-4 strains with complete genome
sequences are recorded in the NCBI GenBank database
(accessed January 2011), and all 87 strains were predicted
to be detected by the primer cocktail (using MegaBLAST
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[22]), speciﬁcally by the primer pair 1G5P30 with perfect
primer match.
The genotype classiﬁcation of each strain was determined
either by referring to the published literature [28–34] or by
using the Dengue Genotype Determination Tool of the
Viral Bioinformatics Research Center (http://denguedb.org),
which uses paup to generate the phylogenetic tree location
for the query sequence. Of the 516 strains analyzed, 140
belong to DENV-1, 228 to DENV-2 and 148 to DENV-3.
The genotype and source country of each strain analyzed
are provided in Table S6. Strain geographical distribution
information was obtained from NCBI GenBank and the
NIAID Virus Pathogen Database and Analysis Resource
(ViPR) online (http://www.viprbrc.org).
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Table S6. Dengue genotypes predicted to be detected.
Table S7. Amplicon locations of primers used in the
study.
Table S8. Reaction conditions giving the highest PCR
ampliﬁcation efﬁciency for each individual primer pair
used in the ‘cocktail’.
This supplementary material can be found in the
online version of this article.
Please note: As a service to our authors and readers,
this journal provides supporting information supplied
by the authors. Such materials are peer-reviewed and
may be re-organized for online delivery, but are not
copy-edited or typeset. Technical support issues arising
from supporting information (other than missing ﬁles)
should be addressed to the authors.
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